Q3 2025 Management View Jay Short, Co-Founder, CEO & Chairman, emphasized that BioAtla is "currently in advanced stages to ...

The next big advantage isn’t just AI — it’s smarter leadership. CXO 3.0 is where confidence, trust and intelligence drive ...

Globalstar, Inc. is rated a Strong Buy with a $69/share price target, citing future margin expansion and revenue growth. Read more on GSAT stock here.

X9, Inc. today announced positive results from its first-in-human clinical feasibility study evaluating the X9 Ultrasound ...

Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected acquisition ...

Putting the evidence together, it becomes clear that regulation and business models are late-stage refinements, not root ...

Monash University’s vice chancellor says she’s kept “awake at night” by how to make “campuses safe and respectful” after ...

Combine structured frameworks with a customizable assessment model to turn strategic fog into prioritized remediation plans ...

Although personality isn’t fixed. A Type A can soften into Type B after burnout, while a Type D may grow assertive through therapy or leadership roles ...

The international break may be a necessity (especially during a World Cup year), but it remains an annoying one. With no ...

Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities ...

CISOs still struggle to prove the value of their security programs using metrics that their business leaders so desperately ...